Brugada syndrome

Revision as of 19:45, 5 August 2016 by Kxl328 (talk | contribs)

Background

  • Consider as cause of syncope in patients with family history of sudden death
  • 80% of Brugada syndrome diagnosed only after a cardiac arrest[1]
  • Autosomal dominant Na-channelopathy which increases the risk of sudden cardiac death (~10%/yr)[2]
  • Much more common in men (up to 9x), particularly Southeast Asian males
  • ECG shows incomplete RBBB with ST elevation in V1-V3
    • In uncomplicated RBBB, usually there no ST change to slight ST depression
    • If presenting symptom is chest pain rather than syncope, consider strongly STEMI

Clinical Features

  • Typically asymptomatic
  • ECG findings can be more prominent during times of illness or fever
  • Patients may have Vfib arrest or sudden death
  • Diagnostic EKG findings transient and variable, with only 1/3 of serial EKGs diagnostic in confirmed spontaneous coved-type Brugada syndrome pts[3]

Differential Diagnosis

ST Elevation

Evaluation

ECG Criteria

Note - ECG findings can be transient

  • Type 1-Elevated ST segment (>2mm) descends with upward convexity to a TWI
  • Type 2-Elevated ST segment (>1mm) descends toward baseline then rises again (saddleback) to upright T wave
  • Type 3-Elevated ST segment (<1mm) descends toward baseline then rises again to upright T wave

Brugada.jpg

Management

  • Cardiology consultation

Disposition

  • Needs EP consult and VF-inducing electrophysiologic study (EPS), though EPS is controversial prognosticator[4]
  • Inpatient vs outpatient ICD placement
    • Prophylactic ICDs may have risks of complications greater than benefits conferred[5][6]
    • Mortality around 10% per year without ICD placement[citation needed]
    • Antidysrhythmics have no effect on prognosis

External Links

See Also

References

  1. Paul M., Gerss J., Schulze-Bahr E.; Role of programmed ventricular stimulation in patients with Brugada syndrome: a meta-analysis of worldwide published data. Eur Heart J. 28 2007:2126-2133.
  2. Cerrato N, Giustetto C, et al. Prevalence of Type 1 Brugada Electrocardiographic Pattern Evaluated by Twelve-Lead Twenty-Four-Hour Holter Monitoring. The American Journal of Cardiology.115(1). 2015. 52-56.
  3. Richter S., Sarkozy A., Veltmann C.; Variability of the diagnostic ECG pattern in an ICD patient population with Brugada syndrome. J Cardiovasc Electrophysiol. 20 2009:69-75.
  4. Viskin S and Rosso R. Risk of Sudden Death in Asymptomatic Brugada Syndrome: Not as High as We Thought and Not as Low as We Wished…But the Contrary. J Am Coll Cardiol. 2010;56(19):1585-1588.
  5. Sacher F., Probst V., Iesaka Y.; Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study. Circulation. 114 2006:2317-2324.
  6. Rosso R., Glick A., Glikson M.; Outcome after implantation of cardioverter defibrillator in patients with Brugada syndrome: a multicenter Israeli study (ISRABRU). Isr Med Assoc J. 10 2008:435-439.